Clinical Trial Update: Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals [Phase 4]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 4 study comparing 8-week versus 12-week initial follow-up treatment intervals for faricimab in wet age-rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Faculty Hospital Kralovske Vinohrady | Conditions: Wet Age-related Macular Degeneration | Phase 4 | Status: RECRUITING